Soluble CD146 displays angiogenic properties and promotes neovascularization in experimental hind-limb ischemia

Blood

Volumn 115, Issue 18, 2010, Pages 3843-3851

  Harhouri, Karim ^a   Kebir, Abdeldjalil ^a   Guillet, Benjamin ^a   Foucault Bertaud, Alexandrine ^a   Voytenko, Serge ^a   Piercecchi Marti, Marie Dominique ^b   Berenguer, Caroline ^c   Lamy, Edouard ^a   Vely, Frédéric ^a   Pisano, Pascale ^a   Ouafik, L'Houcine ^c   Sabatier, Florence ^a,d   Sampol, José ^a   Bardin, Nathalie ^a   Dignat George, Françoise ^a   Blot Chabaud, Marcel ^a  

^a CNRS   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c University of the Mediterranean Aix Marseille II   (France)

^d HÔPITAL DE LA CONCEPTION   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD146 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GELATINASE A; UROKINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; BIOLOGICAL MARKER; MESSENGER RNA;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; EXPERIMENTAL STUDY; FIBROSIS; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HINDLIMB; IN VITRO STUDY; INFLAMMATION; LASER DOPPLER FLOWMETRY; LIMB ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; TISSUE NECROSIS; UPREGULATION; WESTERN BLOTTING; ANIMAL; DNA MICROARRAY; GENETICS; HUMAN; ISCHEMIA; METABOLISM; MOUSE; NUDE MOUSE; VASCULARIZATION; WOUND HEALING;

ANIMALS; ANTIGENS, CD146; BIOLOGICAL MARKERS; BLOTTING, WESTERN; ENDOTHELIAL CELLS; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HINDLIMB; HUMANS; ISCHEMIA; MALE; MICE; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; WOUND HEALING;

EID: 77952569652     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-06-229591     Document Type: Article

References (41)

1. Bardin N, Anfosso F, Masse JM, et al. Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. Blood. 2001;98(13):3677-3684.
2. Anfosso F, Bardin N, Vivier E, et al. Outside-in signalling pathway linked to CD146 engagement in human endothelial cells. J Biol Chem. 2001;276(2):1564-1569. (Pubitemid 32096592)
3. Anfosso F, Bardin N, Frances V, et al. Activation of human endothelial cells via S-endo-1 antigen (CD146) stimulates the tyrosine phosphorylation of focal adhesion kinase p125 (FAK). J Biol Chem. 1998;273(41):26852-26856. (Pubitemid 28471703)
4. Bardin N, Blot-Chabaud M, Despoix N, et al. CD146 and its soluble form regulate monocyte transendothelial migration. Arterioscler Thromb Vasc Biol. 2009;29(15):746-753.
5. Bu P, Gao L, Zhuang J, et al. Anti-CD146 monoclonal antibody AA98 inhibits angiogenesis via suppression of nuclear factor-kappaB activation. Mol Cancer Ther. 2006;5(11):2872-2878. (Pubitemid 44849014)
6. Yan X, Lin Y, Yang D, et al. A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth. Blood. 2003;102(1):184-191. (Pubitemid 36759653)
7. Kang Y, Wang F, Feng J, et al. Knockdown of CD146 reduces the migration and proliferation of human endothelial cells. Cell Res. 2006;16(3):313-318.
8. Bardin N, Frances V, Combes V, et al. CD146: biosynthesis and production of a soluble form in human cultured endothelial cells. FEBS Lett. 1998;421(1):12-14. (Pubitemid 28068808)
9. Bardin N, Reumaux D, Geboes K, et al. Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease. Inflamm Bowel Dis. 2006;12(1):16-21. (Pubitemid 43032446)
10. Pasquier E, Bardin N, De Saint Martin L, et al. The first assessment of soluble CD146 in women with unexplained pregnancy loss: a new insight? Thromb Haemost. 2005;94(6):1280-1284. (Pubitemid 41819627)
11. Bardin N, Moal V, Anfosso F, et al. Soluble CD146, a novel endothelial marker, is increased in physiopathological settings linked to endothelial junctional alteration. Thromb. Haemost. 2003;90(5):915-920. (Pubitemid 37427862)
12. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: I. Angiogenic cytokines. Circulation. 2004;109(21):2487-2491. (Pubitemid 38720544)
13. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: II. Cell-based therapies. Circulation. 2004;109(22):2692-2697. (Pubitemid 38737912)
14. Presta M, Dell'Era P, Mitola S, et al. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 2005;16(2):159-178. (Pubitemid 40616114)
15. Ylä-Herttuala S, Rissanen TT, Vajanto I, Hartikainen J. Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine. J Am Coll Cardiol. 2007;49(10):1015-1026. (Pubitemid 46349500)
16. Atluri P, Woo YJ. Pro-antigenic cytokines as cardiovascular therapeutics: assessing the potential. Biodrugs. 2008;22(4):209-222. (Pubitemid 351969829)
17. Thurston G. Role of Angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis. Cell Tissue Res. 2003;314(1):61-68. (Pubitemid 37409913)
18. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275(5302):964-967. (Pubitemid 27087709)
19. Yoder MC, Mead LE, Prater D, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood. 2007;109(5):1801-1809. (Pubitemid 46348173)
20. Sieveking DP, Buckle A, Celermajer DS, Martin KC. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol. 2008;51(6):660-668. (Pubitemid 351186872)
21. Delorme B, Basire A, Gentile C, et al. Presence of endothelial progenitor cells, distinct from mature endothelial cells, within human CD146+ blood cells. Thromb Haemost. 2005;94(6):1270-1279. (Pubitemid 41819626)
22. Despoix N,Walzer T, Jouve N, et al. Mouse CD146/MCAM is a marker of natural killer cell maturation. Eur J Immunol. 2008;38(10):2855-2864.
23. Figarella-Branger D, Schleinitz N, Boutiè re-Albanè se B, et al. Platelet endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies. J Rheumatol. 2006;33(8):1623-1630. (Pubitemid 44168836)
24. Reumaux D, Bardin N, Colombel JF, et al. Restoration of soluble CD146 in patients with Crohn's disease treated with the TNF-alpha antagonist infliximab. Inflamm Bowel Dis. 2007;13(10):1315-1317. (Pubitemid 47597788)
25. Neidhart M, Wehrli R, Brühlmann P, et al. Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis. Arthritis Rheum. 1999;42(4):622-630. (Pubitemid 29171981)
26. Proescholdt MA, Heiss JD, Walbridge S, et al. Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. J Neuropathol Exp Neurol. 1999;58(6):613-627. (Pubitemid 29264941)
27. Lin TJ, Issekutz TB, Marshall JS. SDF-1 induces IL-8 production and transendothelial migration of human cord blood-derived mast cells. Int Arch Allergy Immunol. 2001;124(1):142-145.
28. Silvestre JS, Mallat Z, Tedgui A, Levy BI. Post-ischaemic neovascularization and inflammation. Cardiovasc Res. 2008;78(2):242-249.
29. Kertesz N, Krasnoperov V, Reddy R, et al. The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth. Blood. 2006;107(6):2330-2338. (Pubitemid 43345552)
30. Funahashi Y, Hernandez SL, Das I, et al. A notch1 ectodomain construct inhibits endothelial notch signalling, tumor growth, and angiogenesis. Cancer Res. 2008;68(12):4727-4735.
31. Holash J, Davis S, Papadopoulos N, et al. VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc Natl Acad Sci U S A. 2002;99(17):11393-11398. (Pubitemid 34920936)
32. Derycke L, Morbidelli L, Ziche M, et al. Soluble N-cadherin fragment promotes angiogenesis. Clin Exp Metastasis. 2006;23(3-4):187-201. (Pubitemid 44673808)
33. Melter M, Reinders ME, Sho M, et al. Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood. 2000;96(12):3801-3808.
34. Kontos CD, Annex BH. Angiogenesis. Curr Atheroscler Rep. 1999;1(2):165-171.
35. Ferrara N. Vascular endothelial growth factor. Arterioscler Thromb Vasc Biol. 2009;29(6):789-791.
36. Li G, Kalabis J, Xu X, et al. Reciprocal regulation of MelCAM and AKT in human melanoma. Oncogene. 2003;22(44):6891-6899. (Pubitemid 37386689)
37. Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol. 2006;39(5):469-478. (Pubitemid 44714526)
38. Basire A, Sabatier F, Ravet S, et al. High urokinase expression contributes to the angiogenic properties of endothelial cells derived from circulating progenitors. Thromb Haemost. 2006;95(4):678-688.
39. Sasaki K, Heeschen C, Aicher A, et al. Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy. Proc Natl Acad Sci U S A. 2006;103(39):14537-14541. (Pubitemid 44484785)
40. You D, Waeckel L, Ebrahimian TG, et al. Increase in vascular permeability and vasodilation are critical for pro-angiogenic effects of stem cell therapy. Circulation. 2006;114(4):328-338. (Pubitemid 44297099)
41. Grunewald M, Avraham I, Dor Y, et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell. 2006;124(1):175-189. (Pubitemid 43069318)